Five genes that affect the risk of developing heart disease have been discovered by an international consortium of scientists.
Writing in PLoS Genetics, the researchers said the findings add to the growing list of genes, which stands at more than 30, that affect risk of coronary artery disease (CAD) and heart attacks.
It is hoped the discovery could help in developing new treatments and improve prediction of the disease.
Researcher Professor Nilesh Samani, of the British Heart Foundation and Professor of Cardiology University of Leicester, UK, said: “The findings provide new insights into and understanding of the causal biological pathways that cause heart disease, and particularly highlight the role of lipids and inflammation.”
Professor John Danesh, fellow researcher from the University of Cambridge, UK, said: “This is one of the first genetic studies of coronary artery disease to include a significant proportion of subjects of South Asian origin.
“This ethnic group has a higher risk of coronary artery disease. Our study shows that many of the genes that affect risk of coronary artery disease do so similarly in European Caucasians as in South Asians.”
Dr Adam Butterworth, also from the University of Cambridge who co-ordinated the analysis added: “One of the other strengths of our study is that in the literature there were a lot of genes which had been suggested to be associated with coronary artery disease based on small studies.
“Our very large study has allowed us to clarify this literature, and show that most of these reported associations are spurious.”
The consortium examined 49,094 genetic variants in ~ 2,100 genes of cardiovascular relevance, in 15,596 coronary artery disease cases and 34,992 controls and replicated their principal findings in an additional 17,121 cases and 40,473 controls.
The study was funded by the British Heart Foundation and the National Institute for Health Research in the UK with additional funding from the NIH in the USA and from other funding sources in Europe. The work was also supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, based at Glenfield Hospital, Leicester.

Leave a Reply